Gottlieb says new coronavirus strain could be more infectious

Former FDA commissioner Scott Gottlieb says the new coronavirus strain spreading in Europe is probably not more lethal than others, but that early data shows it’s easier to transmit.

• Dec 20, 2020
• 05:11

Moderna vaccine brings more hope

The Moderna vaccine has become the second coronavirus vaccine authorized by the FDA, as the Pfizer vaccine continues to roll out throughout the U.S. The country is in desperate need of more relief from vaccines, as hospitalizations and deaths rise at disturbing rates. Dr. Henry Bernstein joins CBSN to discuss the vaccines and what needs to be done to improve the situation across the nation.

• Dec 16, 2020
• 06:48

Transcript: Scott Gottlieb on "Face the Nation"

The following is a transcript of an interview with former FDA Commissioner Scott Gottlieb that aired December 20, 2020, on "Face the Nation."

• Dec 20, 2020

Moderna vaccine given emergency use authorization

Moderna has become the second coronavirus vaccine in the U.S. to be authorized for emergency use. Dr. Bruce Y. Lee, executive director of public health computational and operations research and professor of public health and management at the City University of New York, joined CBSN with the latest on this vaccine and distribution efforts.

• Dec 19, 2020
• 11:46

Extra Pfizer vaccine doses spur optimism

The FDA granted emergency authorization to Moderna's vaccine. An initial batch of six million doses will begin shipping out this weekend, and Moderna says it hopes to make up to 100 million doses available in the U.S. by March. It comes one week after the approval of Pfizer’s vaccine, which is already being administered. Errol Barnett was the first to report that some vials of the Pfizer vaccine contained extra doses, and is now showing how that was enough to vaccinate even more health care workers and staff at one Cleveland hospital.

• Dec 19, 2020
• 03:41

FDA approves Moderna coronavirus vaccine

A second COVID-19 vaccine has been approved for distribution in the U.S. The FDA’s approval of Moderna’s vaccine Friday night clears the way for the pharmaceutical company to immediately ship millions of doses, likely beginning with hospitals. Tom Hanson is following the developments.

• Dec 19, 2020
• 03:56

Doctor on U.S.-wide vaccination effort

The FDA’s approval of Moderna’s coronavirus vaccine sets the stage for millions of doses to be shipped as early as Sunday. The promising news comes as the U.S. grapples with rising cases. Johns Hopkins Center for Health Security senior scholar Dr. Amesh Adalja joins “CBS This Morning: Saturday” to discuss how the two vaccines will shift the fight against the pandemic.

• Dec 19, 2020
• 03:42

Eye Opener: FDA green lights Moderna vaccine

The FDA issued an emergency use authorization for Moderna’s COVID-19 vaccine. Also, Congress has agreed to fund the government for another two days, giving lawmakers extra time to pass a pandemic relief bill. All that and all that mattes in today’s Eye Opener. Your world in 90 seconds.

• Dec 19, 2020
• 02:09

FDA authorizes Moderna's coronavirus vaccine for emergency use

The authorization allows the vaccine to be distributed to people 18 or older.

• Dec 19, 2020

FDA warns of hidden ingredients in "male enhancement" and diet pills

The FDA tested dozens of weight-loss and sexual performance products and found potentially harmful substances.

• Dec 18, 2020

FDA panel recommends Moderna vaccine

If approved, nearly 6 million doses of the Moderna coronavirus vaccine could be shipped across the country starting this weekend. It comes as hospitals continue to be inundated with COVID-19 patients. David Begnaud reports.

• Dec 18, 2020
• 04:02

Panel recommends use of Moderna COVID-19 vaccine

The FDA is expected to quickly approve the vaccine for emergency use.

• Dec 18, 2020

FDA panel endorses moderna's coronavirus vaccine

An FDA advisory panel has recommended emergency use of Moderna's coronavirus vaccine. The FDA could authorize the vaccine as early as Friday and six million doses could be shipped out next week. This comes as the total number of cases in the U.S. tops 17 million and California becomes the epicenter of the nation's outbreak. Dr. Yves Duroseau, chair of the Department of Emergency Medicine at Lenox Hill Hospital, joins CBSN to discuss how the vaccines work.

• Dec 17, 2020
• 13:02

"CBS Evening News" headlines for December 17, 2020

Here's a look at the top stories making headlines on the "CBS Evening News with Norah O'Donnell."

• Dec 17, 2020
• 01:53

FDA panel votes for Moderna vaccine

A Food and Drug Administration advisory panel voted to recommend Moderna's COVID-19 vaccine for emergency use authorization on Thursday. Meanwhile the rollout of Pfizer's vaccine to frontline health care workers continues. Columbia University professor of epidemiology and medicine Dr. Wafaa El-Sadr joins CBSN's "Red & Blue" anchor Elaine Quijano with more on what the safety data shows.

• Dec 17, 2020
• 07:32

FDA panel endorses Moderna's COVID vaccine

A second coronavirus vaccine could begin shipping this weekend that will provide millions of additional doses to Americans. This comes as the U.S. sets another deadly record as the pandemic surges. Jonathan Vigliotti reports.

• Dec 17, 2020
• 04:15

Extra doses found in Pfizer vaccine vials

Vials of Pfizer's COVID vaccine were found to contain an extra dose as a second vaccine is on its way to approval. Errol Barnett has more.

• Dec 17, 2020
• 02:34

Doctor answers questions on COVID vaccines

Members of an FDA advisory panel voted 20-0 to recommend Moderna's COVID-19 vaccine for emergency use. The FDA could authorize it within days, along with the Pfizer vaccine that health care workers started receiving this week. CBS New York's Dr. Max Gomez answers some common questions about the new vaccines on CBSN NY.

• Dec 17, 2020
• 02:17

FDA panel looks at Moderna's COVID vaccine

The FDA is considering emergency authorization for the Moderna coronavirus vaccine, as the nation continues to break records for daily new cases and deaths. Jennifer Gommerman, a professor of immunology at the University of Toronto, joins CBSN to talk more about the Moderna vaccine and the latest developments with the Pfizer doses.

• Dec 17, 2020
• 04:48

Pfizer vials contain extra vaccine doses

Doctors across the nation this week expected to receive the Pfizer vaccine with five doses in each vial. But to their surprise, they've found there may be more full doses available in each vial than previously thought. Errol Barnett reports.

• Dec 17, 2020
• 02:14

FDA clears way for second COVID-19 vaccine

By the end of the week, the U.S. could have two approved COVID-19 vaccines. The first, by Pfizer, is already being administered to frontline health care workers across the nation. "CBS This Morning" lead national correspondent David Begnaud got an exclusive look as nearly 5,000 doses arrived at the UC Davis Medical Center in Sacramento, California.

• Dec 16, 2020
• 03:22

U.S. nears 17 million cases as vaccine rollout expands

A second coronavirus vaccine could be made available in the U.S. as early as this week. The FDA is expected to authorize Moderna's vaccine for emergency use as cases skyrocket this holiday season. Dr. Leo Nissola is a medical expert and immunotherapy scientist. He joined CBSN to discuss the latest.

• Dec 16, 2020
• 11:03

Health care workers feel spark of hope as vaccinations begin

The FDA said the Moderna vaccine​ overall is 94.5% effective and 100% effective in people 65 and over.

• Dec 16, 2020

FDA says Moderna vaccine is highly effective

Moderna's coronavirus vaccine could soon be part of America's largest mass vaccination effort. The Food and Drug Administration said the vaccine is highly effective and there are "no specific safety concerns," and a panel is expected to consider the pharmaceutical company's application for emergency use this week. This comes as distribution ramps up for Pfizer's vaccine and health care systems are stretched thin as coronavirus infections skyrocket. CBS News correspondent Mola Lenghi reports on the latest developments from New York City, CBS News chief congressional correspondent Nancy Cordes reports from Washington on the need for funding to fight COVID-19, and Dr. Richard Besser, president and CEO of the Robert Wood Johnson Foundation and the former acting director of the Centers for Disease Control and Prevention, joined CBSN to discuss.

• Dec 15, 2020
• 14:13

FDA authorizes first over-the-counter home test for COVID-19

The test, which will be priced around $30, connects to a digital app to help users interpret the results.

• Dec 15, 2020

Show More